Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug cocktails target tough lung cancers

NCT ID NCT06162572

Ongoing Disease control Sponsor: Servier Bio-Innovation LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing three new experimental immunotherapy drugs, each combined with an existing immunotherapy called cemiplimab, for adults with advanced non-small cell lung cancer who haven't had prior treatment. The goal is to see if these combinations are safe and can help control the cancer. The trial will enroll about 100 participants to find the right doses and measure how well the treatments work.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, 20162, Italy

  • Azienda Ospedaliera S. Maria Della Misericordia

    Perugia, 06132, Italy

  • Border Medical Oncology Research Unit

    Albury, 2640, Australia

  • Bugat Pal Hospital

    Gyöngyös, 3200, Hungary

  • CIONC

    Curitiba, 80810-050, Brazil

  • Centre Georges Francois Leclerc

    Dijon, 21079, France

  • Centre René Gauducheau/Inst de Cancér. de L'Ouest

    Saint-Herblain, 44805, France

  • Centro Di Riferimento Oncologico

    Aviano, 33081, Italy

  • Chu Grenoble Alpes

    Grenoble, 38043, France

  • Clinica Universitaria de Navarra (Madrid)

    Madrid, 28027, Spain

  • Clinica Universitaria de Navarra (Pamplona)

    Pamplona, 31008, Spain

  • Comprehensive Cancer Center of Nevada

    Las Vegas, Nevada, 89119, United States

  • Farkasgyepu Tudogyogyintezet

    Farkasgyepű, 8582, Hungary

  • Flinders Medical Centre

    Bedford Park, 5042, Australia

  • Gabrail Cancer Center

    Canton, Ohio, 44718, United States

  • Henry Ford Health

    Detroit, Michigan, 48202, United States

  • Hong Kong United Onology Centre

    Hong Kong, Hong Kong

  • Hospital A C Camargo

    São Paulo, 01509-010, Brazil

  • Hospital Albert Einstein

    São Paulo, 05652-900, Brazil

  • Hospital General Universitario Gregorio Marañón

    Madrid, 28007, Spain

  • Hospital São Camilo

    São Paulo, 03102-002, Brazil

  • Hospital São Lucas Da Pucrs

    Porto Alegre, 90619-900, Brazil

  • Hospital Univ. Hm Sanchinarro Start Ciocc Early Phase

    Madrid, 28050, Spain

  • Hospital Universitario Virgen de La Victoria

    Málaga, 29010, Spain

  • Hospital Universitario Y Politecnico La Fe

    Valencia, 46026, Spain

  • Hospital Virgen Del Rocío

    Seville, 41013, Spain

  • Hospital de Amor - Barretos

    Barretos, 14784-400, Brazil

  • Inst Oncologic "Prof Dr I Chiricuta" Cluj Napoca

    Cluj-Napoca, Romania

  • Inst. Romagnolo Per Lo Studio E La Cura Dei Tumori

    Meldola, 47014, Italy

  • Institut Gustave Roussy

    Villejuif, 94805, France

  • Institut Paoli Calmette

    Marseille, 13009, France

  • Instituto Médico Especializado Alexander Fleming

    Buenos Aires, Argentina

  • Irccs Fondazione Istituto Nazionale Dei Tumori

    Milan, 20133, Italy

  • Ist. Nazionale Tumori Irccs Fondazione G Pascale

    Naples, 80131, Italy

  • Istituto Clinico Humanitas I.R.C.C.S

    Rozzano, 20089, Italy

  • Istituto Europeo Di Oncologia

    Milan, 20141, Italy

  • Istituto Nazionale Tumori Regina Elena

    Roma, 00144, Italy

  • Jessa Ziekenhuis

    Hasselt, 3500, Belgium

  • Latrobe Regional Health

    Traralgon, 3844, Australia

  • Liga Contra O Cancer - Natal

    Natal, 59035-055, Brazil

  • Loma Linda University

    Loma Linda, California, 92354, United States

  • Medical University of Vienna - Akh

    Vienna, 1090, Austria

  • National Taiwan University Hospital

    Taipei, 100225, Taiwan

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, 43210, United States

  • Oncoclinicas Rj

    Rio de Janeiro, 22250-905, Brazil

  • Oncoclinicas Sp

    São Paulo, 04538-132, Brazil

  • Ordensklinikum Linz Elisabethinen

    Linz, 4020, Austria

  • Pecsi Tudomanyegyetem, Klinikai Kozpont

    Pécs, 7624, Hungary

  • Ploiesti Municipal Hospital

    Ploieşti, Romania

  • Prince of Wales Hospital

    Hong Kong, Hong Kong

  • Queen Mary Hospital

    Hong Kong, Hong Kong

  • Sanatorio Parque S.A.

    Santa Fe, Argentina

  • Santa Casa de Porto Alegre

    Porto Alegre, 90020-090, Brazil

  • Sunshine Hospital

    St Albans, 3021, Australia

  • Supera Oncologia

    Chapecó, 89812618, Brazil

  • The Christie Nhs Foundation Foundation Trust

    Manchester, M20 4BX, United Kingdom

  • The Royal Marsden in Chelsea

    London, SW3 6JJ, United Kingdom

  • The Royal Marsden in Sutton

    London, SM2 5PT, United Kingdom

  • Tri-Service General Hospital

    Taipei, 114202, Taiwan

  • Universitatsklinikum St. Poelten

    Sankt Pölten, 3100, Austria

  • Uz Leuven Campus Gasthuisberg

    Leuven, 3500, Belgium

  • Vall D' Hebron Institute of Oncology (Vhio), University Hospital

    Barcelona, 08035, Spain

  • Virginia Cancer Specialists, P.C.

    Fairfax, Virginia, 22031, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER (NSCLC)